PLIANT THERAPEUTICS I

13.46

25-November-24 15:45:01

15 minutes delayed

Stocks

+0.48

+3.70%

Today's range

13.00 - 14.00

ISIN

N/A

Source

NASDAQ

Pliant Therapeutics to Participate in the BTIG Biotechnology Conference

03 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results

10 May 2021 15:21:16 By Nasdaq GlobeNewswire
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

05 May 2021 07:05:00 By Nasdaq GlobeNewswire
Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference

05 Apr 2021 07:00:00 By Nasdaq GlobeNewswire
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

16 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner

16 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
Pliant Therapeutics to Participate in Upcoming Virtual Investor Events

18 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors

12 Jan 2021 07:00:01 By Nasdaq GlobeNewswire
Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF

04 Jan 2021 07:00:01 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.